Clinical trials
Completed Schizophrenia Spectrum and Other Psychotic Disorders trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre for Addiction and Mental Health | 3 |
| Center for Social Innovation, Massachusetts | 1 |
| Chinese University of Hong Kong | 1 |
| Columbia University | 1 |
| Duke University | 1 |
| Fundación Marques de Valdecilla | 1 |
| Indiana University | 1 |
| Instituto de Investigación Hospital Universitario La Paz | 1 |
| Karolinska Institutet | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia Spectrum and Other Psychotic Disorders | 23 |
| Psychotic Disorders | 13 |
| Schizophrenia | 13 |
| Mental Disorders | 5 |
| Affective Disorders, Psychotic | 3 |
| Mood Disorders | 2 |
| Personality Disorders | 2 |
| Substance-Related Disorders | 2 |
| Bipolar Disorder | 1 |
| Cognitive Dysfunction | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.